EDGAR Filing Documents for 0001104659-16-130577

Form 8-K - Current report:

SEC Accession No. 0001104659-16-130577

Filing Date

2016-07-01

Accepted

2016-07-01 07:36:06

Documents

Period of Report

2016-06-30

Items

Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-14278_18k.htm	8-K	19924
	Complete submission text file	0001104659-16-130577.txt		21200

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 161744664
SIC: 2834 Pharmaceutical Preparations